Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Molitch ME. Disorders of prolactin secretion. Endocrinol Metab Clin North Am 2001; 30:585–610.
Barkan AL, Chandler WF. Giant pituitary adenoma with falsely low serum prolactin: the pitfall of the ‘high dose hook effect’. Neurosurgery 1998; 42:913–915.
Hattori N. Macroprolactinemia: a new cause of hyperprolactinemia. J Pharmacol Sci 2003; 92:171–177.
Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. NEJM 2003; 349:2023–2033.
Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, Volpe R, Di Salle F, Cirillo S, Annunziato L, Lombardi G. Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. JCEM 2000; 85:2247–2252.
Lüdecke DK, Herrmann H-D, Hörman C, Desaga U, Saeger W. Microsurgery and combination with dopamine agonist treatment of prolactinomas. In: Prolactin and prolactinomas, eds. Tolis G et al., Raven Press, New York, 1983:453–467.
References
Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A, Ho K, Kleinberg D, Lamberts S, Laws E, Lombardi G, Vance ML, von Werder K, Wass J, Giustina A. Guidelines for acromegaly management. J Clin Endocrinol Metab 2002; 87:4054–8.
Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, von Werder K, Melmed S. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000; 85:526–9.
Lüdecke DK. Recent developments in the treatment of acromegaly. Neurosurg Rev 1985; 8: 167–73.
Freda PU. Somatostatin analogs in acromegaly. J Clin Endocrinol Metab 2002; 87:3013–18.
Clemmons DR, Chihara K, Freda PU, Ho KKY, Klibanski A, Melmed S, Shalet SM, Strasburger CJ, Trainer PJ, Thorner MO. Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab 2003; 88:4759–67.
Biermasz NR, van Dulken H, Roelfsema F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 2000; 85:2476–82.
Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 2003; 88:3105–12.
References
Abe T, Lüdecke DK. Effects of preoperative octreotide treatment on different subtypes of 90 growth hormone-secreting pituitary adenomas and outcome in one surgical center. Eur J Endocrinol 2001; 145:137–45
Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996; 17:610–38.
Buchfelder M, Fahlbusch R. Thyrotroph adenomas. In: Thapar K, Kovacs K, Scheithauer BW, Lloyd RV, eds. Diagnosis and management of pituitary tumors. Totowa, NJ: Human Press, 2001:333–42.
Chanson P, Weintraub BD, Harris AG. Octreotide therapy for thyroid stimulating-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 1993; 119:236–40.
Kourides IA, Ridgway EC, Weintraub BD, Bigos ST, Gershengorn MC, Maloof F. Thyrotropin-induced hyperthyroidism: use of α and β subunit levels to identify patients with primary tumors. J Clin Endocrinol Metab 1977; 45:534–43.
Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 1996; 81:3084–90.
McCutcheon IE, Weintraub BD, Oldfield EH. Surgical treatment of thyreotroph adenomas. J Neurosurg 1990; 73:674–83.
Saeger W, Lüdecke DK. Pituitary adenomas with hyperfunction of TSH: frequency, histological classification, immunocytochemistry and ultrastructure. Virchows Arch [Pathol Anat] 1982; 394:255–67.
References
Asa SL, Kovacs K, Tindall GT, Barrow DL, Horvath E, Vecsei P. Cushing’s disease associated with an intrasellar gangliocytoma producing corticotropin-releasing factor. Ann Intern Med 1984; 101:789–793.
Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932; 50:137–195.
Flitsch J, Spitzner S, Lüdecke DK. Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes 2000; 108:480–485.
Lüdecke DK. Intraoperative measurement of adrenocorticotrophic hormone in peripituitary blood in Cushing’s disease. Neurosurg 1989; 24:201–204.
Lüdecke DK, Flitsch J, Knappe UJ, Saeger W. Cushing’s disease: a surgical view. J Neuro-Oncol 2001; 54:151–166.
Mahmoud-Ahmed AS, Suh JH. Radiation therapy for Cushing’s disease: a review. Pituitary 2002; 5:175–180.
Nelson DH, Meakin JF, Dealy JW, Matson DD, Emerson K, Thorn GW. ACTH-producing tumor of the pituitary gland. N Engl J Med 1958; 259:161–164.
Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998; 19:647–672.
Nieman LK. Medical therapy of Cushing’s disease. Pituitary 2002; 5:77–82.
Oldfield EH, Chrousos GP, Schulte HM, Schaaf M, Mc Keever PE, Krudy AG, Cutler Jr GB, Loriaux DL, Doppman JL. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 1985; 312:100–103.
Saeger W, Wilczak P, Lüdecke DK, Buchfelder M, Fahlbusch R. Hormone markers in pituitary adenomas: Changes within last decade resulting from improved method. Endocri Pathol 2003; 14:49–54.
Semple PL, Laws Jr ER. Complications in a contemporary series of patients who underwent transsphenoidal surgery. J Neurosurg 1999; 91:175–179.
Solcia E, Klöppel G, Sobin LH, Capella C, de Lellis RA, Heitz PhU, Horvath E, Kovacs K, Lack EE, Lloyd RJ, Rosai J, Scheithauer BW. Histological typing of endocrine tumors. 2nd edition. Springer, Berlin-Heidelberg-New York-Barcelona-Hong Kong-London-Milan-Paris-Singapore-Tokyo, 2000
Teramoto A, Nemoto S, Takakura K, Sasaki Y, Machida T. Selective venous sampling directly from the cavernous sinus in Cushing’s syndrome. J Clin Endocrinol Metab 1993; 76:637–641.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lüdecke, D.K., Abe, T., Flitsch, J., Petersen, S., Saeger, W. (2006). Functioning Adenomas. In: Tonn, JC., Grossman, S.A., Rutka, J.T., Westphal, M. (eds) Neuro-Oncology of CNS Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31260-9_12
Download citation
DOI: https://doi.org/10.1007/3-540-31260-9_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25833-9
Online ISBN: 978-3-540-31260-4
eBook Packages: MedicineMedicine (R0)